GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 59 filers reported holding GT BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 1.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -44.8% | 66,700 | -27.6% | 0.00% | – |
| Q2 2023 | $29 | -23.7% | 92,181 | +32.8% | 0.00% | – |
| Q1 2023 | $38 | -7.3% | 69,400 | +50.2% | 0.00% | – |
| Q4 2022 | $41 | -100.0% | 46,200 | -28.6% | 0.00% | – |
| Q2 2022 | $193,000 | -64.1% | 64,701 | -65.3% | 0.00% | -100.0% |
| Q1 2022 | $537,000 | -42.6% | 186,300 | -39.3% | 0.00% | 0.0% |
| Q4 2021 | $935,000 | +63.7% | 306,700 | +262.1% | 0.00% | 0.0% |
| Q3 2021 | $571,000 | – | 84,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |